Admission to trading of Ambea AB (publ) on Nasdaq
Post# of 301275
On request of Ambea AB (publ), company registration number 556468-4354, Nasdaq Stockholm AB has admitted the company’s shares to trading on Nasdaq Stockholm, with effect from March 31, 2017. The decision is conditional upon that Ambea AB (publ) can meet the requirements regarding liquidity.
The company’s share capital consists of 40,239,140[1] shares as per today’s date.
| Short Name: | AMBEA |
| Maximum number of shares to be listed: | 67,616,556[2] |
| ISIN Code: | SE0009663826 |
| Order Book ID: | 135504 |
| Average Daily Turnover: | 2,000,000 EUR |
| Clearing: | CCP cleared |
| Segment: | Mid Cap |
| Market segment: | STO Equities CCP/182 |
| Tick Size Table: | Other Equities/227 |
| MIC: | XSTO |
ICB Classification:
| Industry code: | 4000 Health care |
| Supersector code: | 4500 Health care |
When issued trading
Trading will be on a when issued basis from March 31, 2017, up and including April 3, 2017, i.e. trading will begin before all conditions in the Offering has been satisfied and will cease if the Offering is not completed. For further information see pages 40-41 and 173 in the prospectus (Sw. version).
For further information concerning this exchange notice please contact Issuer Surveillance, telephone +46 8 405 60 00, or iss@nasdaq.com.
[1] See prospectus page 163 (Sw. version).
[2] See prospectus page 163 (Sw. version).
(0)
(0)